BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12892237)

  • 1. Primary leptomeningeal primitive neuroectodermal tumor.
    Begemann M; Lyden D; Rosenblum MK; Lis E; Wolden S; Antunes NL; Dunkel IJ
    J Neurooncol; 2003 Jul; 63(3):299-303. PubMed ID: 12892237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ-confined primitive neuroectodermal tumor arising from the kidney.
    Lam JS; Hensle TW; Debelenko L; Granowetter L; Tennenbaum SY
    J Pediatr Surg; 2003 Apr; 38(4):619-21. PubMed ID: 12677579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
    Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses.
    von Bueren AO; Warmuth-Metz M; Schlegel PG; Soerensen N; Krauss J; Roggendorf W; Pietsch T; Feiden W; Graf N; Pohl F; Flentje M; Kuehl J; Rutkowski S
    Pediatr Blood Cancer; 2011 Mar; 56(3):503-5. PubMed ID: 21113945
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary diffuse leptomeningeal primitive neuroectodermal tumor presenting as chronic meningitis.
    Koshy KG; Kulkarni GB; Nandeesh BN; Taalapalli AV
    J Postgrad Med; 2024; 70(1):46-49. PubMed ID: 36891942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature.
    Otero-Rodríguez A; Hinojosa J; Esparza J; Muñoz MJ; Iglesias S; Rodríguez-Gil Y; Ricoy JR
    Neurocirugia (Astur); 2009 Aug; 20(4):381-6; discussion 386-7. PubMed ID: 19688140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR; Jubran RF; Allen J; Gardner S; Dunkel IJ; Rosenblum M; Atlas MP; Gonzalez-Gomez I; Miller D; Finlay JL
    Pediatr Blood Cancer; 2008 Mar; 50(3):715-7. PubMed ID: 17009232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primitive neuroectodermal tumor of maxilla in an adult.
    Shah N; Roychoudhury A; Sarkar C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Dec; 80(6):683-6. PubMed ID: 8680976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
    Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
    Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Initial Presentation of Primary Diffuse Leptomeningeal PNET in a 10-Year-Old-Male.
    Lim PP; Ramdas J; Miller MA; Schuerch C; Wu G
    S D Med; 2017 Dec; 70(12):543-545. PubMed ID: 29334442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF
    Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
    Cohen BH; Zeltzer PM; Boyett JM; Geyer JR; Allen JC; Finlay JL; McGuire-Cullen P; Milstein JM; Rorke LB; Stanley P
    J Clin Oncol; 1995 Jul; 13(7):1687-96. PubMed ID: 7602359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
    Chintagumpala M; Hassall T; Palmer S; Ashley D; Wallace D; Kasow K; Merchant TE; Krasin MJ; Dauser R; Boop F; Krance R; Woo S; Cheuk R; Lau C; Gilbertson R; Gajjar A
    Neuro Oncol; 2009 Feb; 11(1):33-40. PubMed ID: 18796696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.